12/02/2004
ReGen Therapeutics Plc (‘ReGen’ or ‘the Company’) announces that it has today placed 18,181,818 million new ordinary shares (‘New Shares’) at 2.75p per share with new and existing shareholders to raise £500,000 before expenses(‘Placing’).
Application has been made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange Plc and dealings are expected to commence at 8 a.m. on 18 February 2004.
Executive Chairman Percy Lomax commented that ‘The proceeds of the issue will be used to explore further opportunities’.
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No: 020 7960 6007